Related Experiment Video

Updated: Jul 16, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

SUMO and estrogen receptors in breast cancer

Michalis V Karamouzis1, Panagiotis A Konstantinopoulos, Filitsa A Badra

  • 1Department of Biological Chemistry, Medical School, University of Athens, Athens, Greece. papavas@med.uoa.gr

Breast Cancer Research and Treatment
|March 23, 2007
PubMed

Insights

Small ubiquitin-like modifier (SUMO) proteins regulate gene transcription by modifying proteins like estrogen receptors, impacting breast cancer development and treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Small ubiquitin-like modifier (SUMO) proteins are structurally similar to ubiquitin and attach to target proteins.
  • Unlike ubiquitination, SUMOylation does not cause protein degradation but modulates protein function.
  • SUMOylation affects diverse cellular processes, including DNA binding and transcription factor activity.

Purpose of the Study:

  • To investigate the role of SUMO proteins in estrogen receptor (ER)-mediated transcription.
  • To explore the contribution of SUMOylation to breast carcinogenesis.
  • To understand SUMOylation's impact on endocrine therapy sensitivity and resistance.

Main Methods:

  • The study focuses on the functional consequences of SUMOylation on target proteins.
  • Investigates SUMOylation's influence on estrogen receptor signaling pathways.
  • Examines tissue and state-specific SUMOylation patterns.

Main Results:

  • SUMOylation modifies key functional properties of target proteins, including subcellular localization and DNA binding.
  • SUMO proteins influence the activity of transcription factors, notably estrogen receptors.
  • SUMOylation may affect transcriptional co-factor complexes in the ER signaling cascade.

Conclusions:

  • SUMOylation plays a critical role in regulating estrogen receptor activity.
  • Understanding SUMOylation in breast cancer can reveal mechanisms of endocrine therapy resistance.
  • Targeting SUMOylation pathways may offer novel therapeutic strategies for breast carcinoma.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...